Search Results - lauren+schewitz+bowers

1 Results Sort By:
Calcineurin Inhibitor-Antibody Conjugates for Targeted Treatment of Th17 Driven Inflammatory Diseases
The National Eye Institute (NEI) seeks research co-development partners and/or licensees for the development of calcineurin inhibitor-antibody conjugates aimed at treating Th17 driven inflammatory diseases. This technology includes calcineurin inhibitor-antibody conjugates designed for the targeted treatment of Th17 driven inflammatory diseases, such...
Published: 6/16/2026   |   Updated: 6/16/2026   |   Inventor(s): Andrew Dick, Lauren Schewitz Bowers, Robert Nussenblatt, Lai Wei, Igal Gery, Richard Lee
Keywords(s):  
Category(s): Application > Therapeutics, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, ResearchProducts > Antibodies, TherapeuticArea > Immunology, TherapeuticArea > Ophthalmology, TherapeuticArea > Neurology